Mitoxantrone, prednimustine, and vincristine for elderly patients with aggressive non-Hodgkin's lymphoma
Jonathan C. Yau(Ottawa Regional Cancer Foundation), Glenwood Goss(Ottawa Hospital), C. Cripps(Canadian Partnership Against Cancer), Colin Germond(Northeast Cancer Centre), D Lister(Ottawa Hospital), Stefan Glück(Northeast Cancer Centre), Bruce F. Burns(Ottawa Hospital), Terry Koski(Northeast Cancer Centre), Shailendra Verma(University of Lucknow)
American Journal of Hematology
October 1, 1998
Cited by 6
Related Papers
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
|New England Journal of Medicine|2018|2.9k
Probability of Cancer in Pulmonary Nodules Detected on First Screening CT
|New England Journal of Medicine|2013|1.4k
PANCREOX: A Randomized Phase III Study of Fluorouracil/Leucovorin With or Without Oxaliplatin for Second-Line Advanced Pancreatic Cancer in Patients Who Have Received Gemcitabine-Based Chemotherapy
|Journal of Clinical Oncology|2016|291
Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective study
|The Lancet Oncology|2017|222
Phase III Trial of Fluorouracil-Based Chemotherapy Regimens Plus Radiotherapy in Postoperative Adjuvant Rectal Cancer: GI INT 0144
|Journal of Clinical Oncology|2006|167